Blastomycosis. 3. A comparative study of 2-hydroxystilbamidine and amphotericin B therapy.
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001759:Blastomycosis / Q000188:drug therapy*; D001847:Bone Diseases / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013266:Stilbamidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014570:Urologic Diseases / Q000188:drug therapy
D013266:Stilbamidines; D000666:Amphotericin B